Abstract:Fibroblast growth factor-inducible 14 (Fn14) is a member of the tumor necrosis factor (TNF) receptor superfamily (TNFRSF) and is activated by its ligand TNF-like weak inducer of apoptosis (TWEAK). The latter occurs as a homotrimeric molecule in a soluble and a membrane-bound form. Soluble TWEAK (sTWEAK) activates the weakly inflammatory alternative NF-κB pathway and sensitizes for TNF-induced cell death while membrane TWEAK (memTWEAK) triggers additionally robust activation of the classical NF-κB pathway and various MAP kinase cascades. Fn14 expression is limited in adult organisms but becomes strongly induced in non-hematopoietic cells by a variety of growth factors, cytokines and physical stressors (e.g., hypoxia, irradiation). Since all these Fn14-inducing factors are frequently also present in the tumor microenvironment, Fn14 is regularly found to be expressed by non-hematopoietic cells of the tumor microenvironment and most solid tumor cells. In general, there are three possibilities how the tumor-Fn14 linkage could be taken into consideration for tumor therapy. First, by exploitation of the cancer associated expression of Fn14 to direct cytotoxic activities (antibody-dependent cell-mediated cytotoxicity (ADCC), cytotoxic payloads, CAR T-cells) to the tumor, second by blockade of potential protumoral activities of the TWEAK/Fn14 system, and third, by stimulation of Fn14 which not only triggers proinflammtory activities but also sensitizes cells for apoptotic and necroptotic cell death. Based on a brief description of the biology of the TWEAK/Fn14 system and Fn14 signaling, we discuss the features of the most relevant Fn14-targeting biologicals and review the preclinical data obtained with these reagents. In particular, we address problems and limitations which became evident in the preclinical studies with Fn14-targeting biologicals and debate possibilities how they could be overcome.

Tumor Necrosis Factor Receptor Mediates Fibroblast Growth Factor-Inducible 14 Signaling

TWEAK/Fn14 Signaling in Tumors

TWEAK/Fn14 signaling in tumors.

Tumor Necrosis Factor (TNF) Receptor Expression Determines Keratinocyte Fate Upon Stimulation with TNF-Like Weak Inducer of Apoptosis

Targeting fibroblast growth factor (FGF)-inducible 14 (Fn14) for tumor therapy

TWEAK/Fn14 axis is an important player in fibrosis

TWEAK/Fn14 Activation Participates in Skin Inflammation.

TWEAK/Fn14 Activation Participates in Skin Inflammation

Fn14 is regulated via the RhoA pathway and mediates nuclear factor-kappaB activation by Angiotensin II.

The Progress of TWEAK and Its Receptor Fn14 Signal Pathway in Lung Diseases

Fn14 and TNFR2 as regulators of cytotoxic TNFR1 signaling

Fibroblast Growth Factor-Inducible 14: Multiple Roles in Tumor Metastasis.

FGF-inducible 14-kDa protein (Fn14) is regulated via the RhoA/ROCK kinase pathway in cardiomyocytes and mediates nuclear factor-kappaB activation by TWEAK

Experimental Atopic Dermatitis is Dependent on the TWEAK/Fn14 Signaling Pathway

Inhibition of fibroblast growth factor-inducible 14 attenuates experimental tubulointerstitial fibrosis and profibrotic factor expression of proximal tubular epithelial cells

The TNFSF12/TWEAK Modulates Colonic Inflammatory Fibroblast Differentiation and Promotes Fibroblast-Monocyte Interactions

Inhibition of fibroblast growth factor-inducible 14 (Fn14) attenuates experimental tubulointerstitial fibrosis and profibrotic factor expression of proximal tubular epithelial cells

Fn14, a Downstream Target of the TGF-β Signaling Pathway, Regulates Fibroblast Activation

TWEAK/Fn14 Signaling May Function As a Reactive Compensatory Mechanism Against Extracellular Matrix Accumulation in Keloid Fibroblasts.

Tumor Necrosis Factor Receptor-Associated Factor Regulation of Nuclear Factor κB and Mitogen-Activated Protein Kinase Pathways

TWEAK/Fn14 Signals Mediate Burn Wound Repair.